Form 4: Director Receives AN2 Therapeutics Stock

Gilbert Lynn Marks, a Director at AN2 Therapeutics, Inc., acquired 2,789 shares of common stock on July 10, 2026, issued in lieu of cash compensation.

Summary

• Gilbert Lynn Marks, a Director of AN2 Therapeutics, Inc., received 2,789 shares of common stock on July 10, 2026.
• These shares were issued as part of the company's non-employee director compensation policy, in lieu of cash payment.
• The shares vest immediately upon issuance.
• Following this transaction, Mr. Marks beneficially owns 81,873 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard compensation transaction for a director rather than a significant financial event or strategic shift.

Positives

• Director compensation is being paid in stock, aligning director interests with shareholders.
• Immediate vesting of shares indicates confidence in the company's near-term prospects.
• The director's beneficial ownership has increased, demonstrating continued commitment.

Future Outlook

No specific future outlook or guidance is provided in this filing, as it pertains to a director's stock award.

Industry Context

StockSavvy.ai notes that the issuance of stock as compensation for non-employee directors is a common practice in the biotechnology and pharmaceutical sectors, aiming to conserve cash while incentivizing leadership.

Related Party Transactions

• The acquisition of 2,789 shares by Director Gilbert Lynn Marks is a related party transaction, as it is part of the company's compensation policy for its non-employee directors.

Stakeholder Impact

• Shareholders: The issuance of stock for compensation dilutes existing shareholders slightly but aligns director incentives with long-term shareholder value.
• Employees: This filing does not directly impact employees.
• Management: Reinforces the compensation structure for the board of directors.

Key Dates

Keywords

AN2 Therapeutics, ANTX, Form 4, Director Compensation, Stock Award, Beneficial Ownership, Securities Exchange Act